The rate of skin cancer in the United States increased for both sexes from 1999 to 2021, with the rate for males consistently higher than that of females. This statistic shows the incidence rate of skin cancer in the U.S. from 1999 to 2021, by gender, per 100,000 population.
In 2022, Australia had the fourth-highest total number of skin cancer cases worldwide and the highest age-standardized rate, with roughly 37 cases of skin cancer per 100,000 population. The graph illustrates the rate of skin cancer in the countries with the highest skin cancer rates worldwide in 2022.
As of 2021, non-Hispanic white people in the United States had the highest incidence rates of skin cancer among all races and ethnicities. Skin cancer is one of the most commonly occurring cancers in the world. Furthermore, the United States is among the countries with the highest rates of skin cancer worldwide. Skin cancer in the U.S. There are a few different types of skin cancer and some are more deadly than others. Basal and squamous skin cancers are more common and less dangerous than melanomas. Among U.S. residents, skin cancer has been demonstrated to be more prevalent among men than women. Skin cancer is also more prevalent among older adults. With treatment and early detection, skin cancers have a high survival rate. Fortunately, in recent years the U.S. has seen a reduction in the rate of death from melanoma. Skin cancer prevention Avoiding and protecting exposed skin from the sun (and other sources of UV light) is the primary means of preventing skin cancer. However, a survey of U.S. adults from 2024 found that around ******* never used sunscreen.
In 2021, Utah had the highest rate of skin cancer, with an estimated ** people out of 100,000 diagnosed with melanoma or another non-epithelial skin cancer. This statistic shows the incidence rate of skin cancer in the U.S. in 2021, by state, per 100,000 population.
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
The Get Data Out programme from the National Disease Registration Service publishes detailed statistics about small groups of cancer patients in a way that ensures patient anonymity is maintained. The Get Data Out programme currently covers 15 cancer sites. This data release is a corrected re-release of detailed statistics for 2013-2019 treatment data. The correction means that surgery counts are no longer slightly underreported. There are some small changes in group sizes of usually no more than 2%, although this is larger for non-melanoma skin cancers. The 15 cancer sites now covered by Get Data Out are: ‘Bladder, Urethra, Renal Pelvis and Ureter’, ‘Bone cancer’, ‘Brain, meningeal and other primary CNS tumours’, ‘Eye cancer’, ‘Head and neck’, ‘Kaposi sarcoma’, ‘Kidney’, ‘Oesophageal and Stomach’, ‘Ovary, fallopian tube and primary peritoneal carcinomas’, ‘Pancreas’, ‘Prostate’, ‘Sarcoma’, ‘Skin tumours’, ‘Soft tissue and peripheral nerve cancer’, ‘Testicular tumours including post-pubertal teratomas’. Anonymisation standards are designed into the data by aggregation at the outset. Patients diagnosed with a certain type of tumour are divided into many smaller groups, each of which contains approximately 100 patients with the same characteristics. These groups are aimed to be clinically meaningful and differ across cancer sites. For each group of patients, Get Data Out routinely publish statistics about incidence, routes to diagnosis, treatments and survival. All releases and documentation are available on the Get Data Out main technical page. Before using the data, we recommend that you read the guide for first time users. The data is available in an open format for anyone to access and use. We hope that by releasing anonymous detailed data like this we can help researchers, the public and patients themselves discover more about cancer. If you have feedback or any other queries about Get Data Out, please email us at NDRSenquires@nhs.net and mention 'Get Data Out' in your email.
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
This release summarises the diagnoses in 2019 registered by NDRS covering all registerable neoplasms (all cancers, all in situ tumours, some benign tumours and all tumours that have uncertain or unknown behaviours)
In 2021, around 13,883 people aged 70 to 74 years were diagnosed with melanoma of the skin or another non-epithelial skin cancer, the highest number of any age group. This statistic shows the number of new skin cancer cases in the U.S. in 2021, by age.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Genes identified by CNx to underpin stromal barrier
It was predicted that in 2025 there would be a total of ******* new melanoma skin cancer cases in the United States, of which ****** would occur in California. This statistic shows the estimated number of new cases of melanoma of the skin in the U.S. in 2025, by state.
U.S. Government Workshttps://www.usa.gov/government-works
License information was derived automatically
For current version see: https://data.sandiegocounty.gov/Health/2021-Non-Communicable-Chronic-Diseases/v7dt-rwpx
Basic Metadata *Rates per 100,000 population. Age-adjusted rates per 100,000 2000 US standard population.
**Blank Cells: Rates not calculated for fewer than 5 events. Rates not calculated in cases where zip code is unknown.
***API: Asian/Pacific Islander. ***AIAN: American Indian/Alaska Native.
Prepared by: County of San Diego, Health & Human Services Agency, Public Health Services, Community Health Statistics Unit, 2019.
Code Source: ICD-9CM - AHRQ HCUP CCS v2015. ICD-10CM - AHRQ HCUP CCS v2018. ICD-10 Mortality - California Department of Public Health, Group Cause of Death Codes 2013; NHCS ICD-10 2e-v1 2017.
Data Guide, Dictionary, and Codebook: https://www.sandiegocounty.gov/content/dam/sdc/hhsa/programs/phs/CHS/Community%20Profiles/Public%20Health%20Services%20Codebook_Data%20Guide_Metadata_10.2.19.xlsx
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Pathways enriched for genes downregulated in tumours with high stromal clustering
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Description of the patients, biopsy sites and dates for the sequential sample cohort.
This statistic shows the amount of registrations of newly diagnosed cases of skin cancer in England in 2022, by age group and gender. Almost 1.5 thousand new cases were recorded among men aged 75 to 79 years of age. It should be noted that the number of people in England in each age group varies and is therefore not necessarily a reflection of susceptibility to skin cancer.
Financial overview and grant giving statistics of Arizona Skin Cancer Foundation
Financial overview and grant giving statistics of Skin Cancer Foundation
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Pathways enriched for genes upregulated in tumours with high stromal barrier
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Genes identified by CNx to underpin stromal clustering
In Denmark in 2022, the incidence of melanoma skin cancer was over 120 percent higher than in the European Union as a whole. The rates of skin cancer in the Netherlands and Sweden were also significantly above the EU average. Tis statistic displays the incidence of melanoma skin cancer in European Union countries compared to the EU-27 overall average in 2022.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Supplementary Materials: Demographic Characteristics (Table 1) and Skin Cancer Prevalence and Risk Factors with Differing Markers of Acculturation (Table 2)
The quarterly emergency presentations of cancer data has been updated by Public Health England’s National Cancer Registration and Analysis Service (NCRAS).
Data estimates are for all malignant cancers (excluding non-melanoma skin cancer) and are at Clinical Commissioning Group (CCG) level, with England as a whole for comparison.
This latest publication includes quarterly data for April 2020 to September 2020 (quarter 1 and 2 of financial year 2020 to 2021) and an update of the one year rolling average.
The proportion of emergency presentations for cancer is an indicator of patient outcomes.
The rate of skin cancer in the United States increased for both sexes from 1999 to 2021, with the rate for males consistently higher than that of females. This statistic shows the incidence rate of skin cancer in the U.S. from 1999 to 2021, by gender, per 100,000 population.